Books etc.

Most Recent

Cancer's culprit

By | April 1, 2009

Breast cancer's genetic profile calls the cancer stem cell hypothesis into question.

5 Comments

Damage Control

By | March 1, 2009

Researchers unlock a treasure trove of information about how cells sense and respond to DNA damage.

3 Comments

B2AR Laid Bare

By | February 1, 2009

A snapshot of the adrenaline target opens the door to more high-resolution, 3-D crystal structures.

0 Comments

The Disputed Rise of Mammals

By | January 1, 2009

Generating the most complete evolutionary tree for mammals sparks debate and discovery.

4 Comments

Navigating the Nucleosome

By | December 1, 2008

Uncovering genomic instructions for how DNA is packaged reveals a new dimension of the genetic code.

2 Comments

A Potent Protein

By | November 1, 2008

Identifying a key protein behind ALS redirects the fight against the disease.

0 Comments

Impeding PD-1

By | October 1, 2008

The discovery that blocking an inhibitory immune receptor restores T cell function in HIV sheds light on immune dysfunction.

1 Comment

Canvassing Protein Complexes

By | September 1, 2008

Two yeast studies begin to identify protein interactions on a genome-wide scale.

1 Comment

Restructuring Human Variation

By | August 1, 2008

Investigators put deletions on the map of human genetic variation.

1 Comment

Calcium Signaling Out of the Gate

By | July 1, 2008

Uncovering the molecular identity of a strange cellular channel triggers a rush of discoveries in calcium regulation.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech